NEOGENOMICS INC|4Feb 28, 6:37 PM ET

BRODIE STEVEN G. 4

4 · NEOGENOMICS INC · Filed Feb 28, 2018

Form 4

Period: 2018-02-26

Chief Scientific Officer

Transactions

Award
Stock Option (Right to Buy)
2018-02-26$8.03/sh+58,000$465,740→ 58,000 total
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (58,000 underlying)

Holdings

Common Stock
32,619
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (13,334 underlying)
13,334
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying)
100,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying)
120,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (50,000 underlying)
50,000

Footnotes (5)

[F1]On March 5, 2014, Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date. On July 5, 2017, Dr. Brodie exercised 6,666 options leaving a balance of 13,334.
[F2]On May 4, 2015, Dr. Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
[F3]On April 20, 2016, Dr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
[F4]On April 28, 2017, Dr. Brodie was granted 50,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
[F5]On February 26, 2018, Dr. Brodie was granted 58,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.

Documents

1 file